Occupation or Discipline – Page 10

FDA Approves Axsome’s Symbravo for Acute Migraine Treatment, Overcoming 2022 Rejection

9 months ago talkbio0Tagged acute, Approved, meloxicam, Migraine Disorders, MoSEIC, rizatriptan, Symbravo, Technology, United States Food and Drug Administration

Symbravo, Axsome Therapeutics, FDA approval, acute migraine treatment, meloxicam, rizatriptan, MoSEIC technology

Dual Hormone Therapies Normalize Sleep Patterns in ALS Mouse Models

9 months ago talkbio0Tagged Amyotrophic Lateral Sclerosis, Architecture, House mice, melanin-concentrating hormone, orexins, Sleep, Sleep disturbances, Study models, suvorexant

Amyotrophic lateral sclerosis (ALS), sleep disturbances, orexin antagonist, melanin-concentrating hormone (MCH), suvorexant, sleep architecture, mouse models

AstraZeneca Invests $570M in Canadian Expansion, Creating 700 New Jobs

9 months ago talkbio0Tagged AstraZeneca, Canadian, Clinical Trials, Drug Industry, expansion, Investments, R&D

AstraZeneca, Canadian expansion, $570M investment, 700 new jobs, life sciences, R&D, clinical trials, pharmaceutical industry

NVIDIA’s AI Innovations: Pioneering the Future of Artificial Intelligence

10 months ago talkbio0Tagged Accelerated, Artificial Intelligence, Computation (action), Generative AI, Health care facility, innovations, NVIDIA AI, Robotics

NVIDIA AI Innovations, Generative AI, Accelerated Computing, Robotics, AI in Healthcare, AI Foundation Models

Synaffix Expands ADC Licensing Partnerships with Boehringer Ingelheim and Mitsubishi Tanabe

10 months ago talkbio0Tagged Boehringer, Cancer Therapeutic Procedure, Ingelheim, licensing agreement, Mitsubishi Tanabe, Neoplasms, Synaffix, Technology, therapeutic autologous dendritic cells

Synaffix, Boehringer Ingelheim, Mitsubishi Tanabe, ADC technology, oncology, cancer treatment, licensing agreement

Sanofi Partners with Alloy Therapeutics in $400M Deal to Advance Antisense Therapeutics

10 months ago talkbio0Tagged Alloys, Antisense, biobucks, Genetic Medicine, sanofi

Sanofi, Alloy Therapeutics, Antisense Therapeutics, Biobucks Deal, Genetic Medicine

Sanofi and Alloy Therapeutics Collaborate on CNS Drug Development Using AntiClastic Antisense Platform

10 months ago talkbio0Tagged Alloys, AntiClastic Antisense Platform, Blood - brain barrier anatomy, Clinical Nurse Specialists, Drug Development, Genetic Medicine, RNA, sanofi

Sanofi, Alloy Therapeutics, AntiClastic Antisense Platform, CNS drug development, blood-brain barrier, RNA therapeutics, genetic medicine

FDA Introduces New Guidance on AI for Drug Approval Submissions in 2025

10 months ago talkbio0Tagged Advice, Artificial Intelligence, Drug Approval, Drug Development, Medical Devices, regulatory decision-making, United States Food and Drug Administration

FDA, AI, drug approval, guidance, regulatory decision-making, medical devices, artificial intelligence, drug development

Regeneron Expands Ophthalmology Portfolio with Acquisition of UK-Based Biotech Oxular

10 months ago talkbio0Tagged Acquisition, biotech, Drug Delivery Systems, Ophthalmology specialty, Oxular, Regeneron, Retinal Diseases, Technology

Regeneron, Oxular, Biotech Acquisition, Ophthalmology, Retinal Disorders, Drug Delivery Technology

Novo Nordisk and Photys Therapeutics Collaborate on Novel Proximity-Based Therapeutics for Cardiometabolic Diseases

11 months ago talkbio0Tagged cardiometabolic diseases, Nordisk, PHICS, proximity-based, research collaboration, Technology

Novo Nordisk, Photys Therapeutics, Cardiometabolic diseases, Proximity-based therapeutics, PHICS technology, Research collaboration